1043 related articles for article (PubMed ID: 12687597)
1. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
2. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
[TBL] [Abstract][Full Text] [Related]
3. Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.
Ballabh P; Kumari J; Krauss AN; Shin JJ; Jain A; Auld PA; Lesser ML; Cunningham-Rundles S
Pediatrics; 2003 Mar; 111(3):461-8. PubMed ID: 12612222
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
[TBL] [Abstract][Full Text] [Related]
6. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
[TBL] [Abstract][Full Text] [Related]
7. [Bronchopulmonary dysplasia].
Clément A
Rev Mal Respir; 1996 Jul; 13(3):243-9. PubMed ID: 8765916
[TBL] [Abstract][Full Text] [Related]
8. Activation of T cells in preterm infants with respiratory distress syndrome.
Turunen R; Vaarala O; Nupponen I; Kajantie E; Siitonen S; Lano A; Repo H; Andersson S
Neonatology; 2009; 96(4):248-58. PubMed ID: 19468239
[TBL] [Abstract][Full Text] [Related]
9. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
[TBL] [Abstract][Full Text] [Related]
10. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.
Groneck P; Götze-Speer B; Oppermann M; Eiffert H; Speer CP
Pediatrics; 1994 May; 93(5):712-8. PubMed ID: 8165067
[TBL] [Abstract][Full Text] [Related]
11. Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia.
Kewitz G; Wudel S; Hopp H; Hopfenmüller W; Vogel M; Roots I
J Perinat Med; 2008; 36(4):359-64. PubMed ID: 18598128
[TBL] [Abstract][Full Text] [Related]
12. [Bronchopulmonary dysplasia--a one-year material].
Farstad T; Bratlid D
Tidsskr Nor Laegeforen; 1990 Aug; 110(19):2524-7. PubMed ID: 2219011
[TBL] [Abstract][Full Text] [Related]
13. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants.
Wadhawan R; Oh W; Perritt R; Laptook AR; Poole K; Wright LL; Fanaroff AA; Duara S; Stoll BJ; Goldberg R
J Perinatol; 2007 Jun; 27(6):359-64. PubMed ID: 17443198
[TBL] [Abstract][Full Text] [Related]
14. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
Yoder BA; Harrison M; Clark RH
Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors for bronchopulmonary dysplasia in neonates with respiratory distress syndrome].
Chen Y; Han YK; Ye ZZ; Lu GJ
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):15-8. PubMed ID: 17306069
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil and monocyte adhesion molecules in bronchopulmonary dysplasia, and effects of corticosteroids.
Ballabh P; Simm M; Kumari J; Krauss AN; Jain A; Califano C; Lesser ML; Cunningham-Rundles S
Arch Dis Child Fetal Neonatal Ed; 2004 Jan; 89(1):F76-83. PubMed ID: 14711863
[TBL] [Abstract][Full Text] [Related]
17. Is it safer to intubate premature infants in the delivery room?
Aly H; Massaro AN; Patel K; El-Mohandes AA
Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
[TBL] [Abstract][Full Text] [Related]
18. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
[TBL] [Abstract][Full Text] [Related]
19. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH
Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
[TBL] [Abstract][Full Text] [Related]
20. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
